KOBAYASHI Pharmaceutical

KOBAYASHI Pharmaceutical

4967.TPre-clinical
Osaka, JapanFounded 1919kobayashi.co.jp

Kobayashi Pharmaceutical is a major Japanese player in the self-medication and consumer health market, with a history spanning over a century. The company has built a robust business model around developing, manufacturing, and marketing a wide array of OTC pharmaceuticals, quasi-drugs, functional foods, and household products. Its strategy focuses on brand power, channel strength, and continuous product innovation to address everyday health and wellness needs, with significant operations across Asia and a growing international presence.

Market Cap
$2.6B
Founded
1919
Employees
2,000-3,000
Focus
Biotech

4967.T · Stock Price

USD 5592.004178.00 (-42.76%)

Historical price data

AI Company Overview

Kobayashi Pharmaceutical is a major Japanese player in the self-medication and consumer health market, with a history spanning over a century. The company has built a robust business model around developing, manufacturing, and marketing a wide array of OTC pharmaceuticals, quasi-drugs, functional foods, and household products. Its strategy focuses on brand power, channel strength, and continuous product innovation to address everyday health and wellness needs, with significant operations across Asia and a growing international presence.

Technology Platform

Expertise in formulation science for topical dermatological products, functional ingredient development for OTC medicines and supplements, and consumer-centric product design for the self-medication market.

Funding History

1
IPOUndisclosedUndisclosedDec 15, 1999

Opportunities

Significant growth potential lies in expanding its successful OTC and consumer health brands into high-growth Asian markets like China and Southeast Asia.
Additionally, developing new product categories linked to wellness, beauty-from-within, and digital health integration presents avenues for capturing new consumer trends.

Risk Factors

Key risks include market saturation and intense competition in its domestic Japanese market, execution challenges in international expansion, and potential regulatory changes affecting OTC product classifications or claims.
Reputational damage from any product safety issue is a constant threat to its brand-centric business.

Competitive Landscape

Faces competition from domestic giants like Taisho Pharmaceutical and SS Pharmaceutical, as well as global consumer health leaders like Kenvue (J&J) and Bayer. Kobayashi differentiates through its deep-rooted, trusted brands in Japan, strong formulation expertise in topical products, and a direct understanding of regional Asian consumer preferences.

Publications
20
Patents
20

Company Info

TypeTherapeutics
Founded1919
Employees2,000-3,000
LocationOsaka, Japan
StagePre-clinical
RevenueRevenue Generating

Trading

Ticker4967.T
ExchangeTSE

Therapeutic Areas

DermatologyGastroenterologyGeneral Health & WellnessRespiratory Health

Partners

Various retail and distribution partners across Asia
SIMILAR COMPANIES
Otsuka Holdings
Otsuka Holdings
Pre-clinical · Tokyo
Shionogi
Shionogi
Pre-clinical · Osaka
Chugai Pharmaceutical
Chugai Pharmaceutical
Pre-clinical ·
Astellas Pharma
Astellas Pharma
Pre-clinical ·
Ono Pharmaceutical
Ono Pharmaceutical
Pre-clinical ·
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile